Fig. 8.
Cytotoxicity assay of the purified CD8+IFN-γ+ and CD8+IFN-γ− after sensitization with autologous EBV BLCL of donor A.
(A) Specific cytotoxic potential of the autologous target of the CD8+IFN-γ+ cells; allogeneic BLCL are not recognized. (B) Little anti-EBV or anti-alloreactive cytolytic activity of the CD8+IFN-γ− subpopulation.